These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia. Gomperts SN; Locascio JJ; Rentz D; Santarlasci A; Marquie M; Johnson KA; Growdon JH Neurology; 2013 Jan; 80(1):85-91. PubMed ID: 23243071 [TBL] [Abstract][Full Text] [Related]
6. β-Amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy. Shimada H; Shinotoh H; Hirano S; Miyoshi M; Sato K; Tanaka N; Ota T; Fukushi K; Irie T; Ito H; Higuchi M; Kuwabara S; Suhara T Mov Disord; 2013 Feb; 28(2):169-75. PubMed ID: 23225334 [TBL] [Abstract][Full Text] [Related]
7. Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic review. Petrou M; Dwamena BA; Foerster BR; MacEachern MP; Bohnen NI; Müller ML; Albin RL; Frey KA Mov Disord; 2015 Jun; 30(7):928-35. PubMed ID: 25879534 [TBL] [Abstract][Full Text] [Related]
8. PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies. Gomperts SN; Marquie M; Locascio JJ; Bayer S; Johnson KA; Growdon JH Neurodegener Dis; 2016; 16(1-2):118-24. PubMed ID: 26655867 [TBL] [Abstract][Full Text] [Related]
9. Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics. Maetzler W; Liepelt I; Reimold M; Reischl G; Solbach C; Becker C; Schulte C; Leyhe T; Keller S; Melms A; Gasser T; Berg D Neurobiol Dis; 2009 Apr; 34(1):107-12. PubMed ID: 19162186 [TBL] [Abstract][Full Text] [Related]
10. Topography of cortical thinning in the Lewy body diseases. Ye R; Touroutoglou A; Brickhouse M; Katz S; Growdon JH; Johnson KA; Dickerson BC; Gomperts SN Neuroimage Clin; 2020; 26():102196. PubMed ID: 32059167 [TBL] [Abstract][Full Text] [Related]
11. Imaging beta-amyloid burden in aging and dementia. Rowe CC; Ng S; Ackermann U; Gong SJ; Pike K; Savage G; Cowie TF; Dickinson KL; Maruff P; Darby D; Smith C; Woodward M; Merory J; Tochon-Danguy H; O'Keefe G; Klunk WE; Mathis CA; Price JC; Masters CL; Villemagne VL Neurology; 2007 May; 68(20):1718-25. PubMed ID: 17502554 [TBL] [Abstract][Full Text] [Related]
12. Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body disease. Shirvan J; Clement N; Ye R; Katz S; Schultz A; Johnson KA; Gomez-Isla T; Frosch M; Growdon JH; Gomperts SN Neurology; 2019 Jul; 93(5):e476-e484. PubMed ID: 31243072 [TBL] [Abstract][Full Text] [Related]
13. In vitro characterization of Pittsburgh compound-B binding to Lewy bodies. Fodero-Tavoletti MT; Smith DP; McLean CA; Adlard PA; Barnham KJ; Foster LE; Leone L; Perez K; Cortés M; Culvenor JG; Li QX; Laughton KM; Rowe CC; Masters CL; Cappai R; Villemagne VL J Neurosci; 2007 Sep; 27(39):10365-71. PubMed ID: 17898208 [TBL] [Abstract][Full Text] [Related]
14. Imaging the role of amyloid in PD dementia and dementia with Lewy bodies. Gomperts SN Curr Neurol Neurosci Rep; 2014 Aug; 14(8):472. PubMed ID: 25011528 [TBL] [Abstract][Full Text] [Related]
15. Striatal Aβ peptide deposition mirrors dementia and differentiates DLB and PDD from other parkinsonian syndromes. Kalaitzakis ME; Walls AJ; Pearce RK; Gentleman SM Neurobiol Dis; 2011 Feb; 41(2):377-84. PubMed ID: 20951207 [TBL] [Abstract][Full Text] [Related]
16. Association of Longitudinal β-Amyloid Accumulation Determined by Positron Emission Tomography With Clinical and Cognitive Decline in Adults With Probable Lewy Body Dementia. Nedelska Z; Schwarz CG; Lesnick TG; Boeve BF; Przybelski SA; Lowe VJ; Kremers WK; Gunter JL; Senjem ML; Graff-Radford J; Ferman TJ; Fields JA; Knopman DS; Petersen RC; Jack CR; Kantarci K JAMA Netw Open; 2019 Dec; 2(12):e1916439. PubMed ID: 31790563 [TBL] [Abstract][Full Text] [Related]
17. Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. Edison P; Rowe CC; Rinne JO; Ng S; Ahmed I; Kemppainen N; Villemagne VL; O'Keefe G; Någren K; Chaudhury KR; Masters CL; Brooks DJ J Neurol Neurosurg Psychiatry; 2008 Dec; 79(12):1331-8. PubMed ID: 18653550 [TBL] [Abstract][Full Text] [Related]
18. PET imaging of brain amyloid in dementia: a review. Quigley H; Colloby SJ; O'Brien JT Int J Geriatr Psychiatry; 2011 Oct; 26(10):991-9. PubMed ID: 21905095 [TBL] [Abstract][Full Text] [Related]
19. Prevalence, distribution, and severity of cerebral amyloid angiopathy differ between Lewy body diseases and Alzheimer's disease. Walker L; Simpson H; Thomas AJ; Attems J Acta Neuropathol Commun; 2024 Feb; 12(1):28. PubMed ID: 38360761 [TBL] [Abstract][Full Text] [Related]
20. β-Amyloid Load on PET Along the Continuum of Dementia With Lewy Bodies. Diaz-Galvan P; Przybelski SA; Lesnick TG; Schwarz CG; Senjem ML; Gunter JL; Jack CR; Min HP; Jain M; Miyagawa T; Forsberg LK; Fields JA; Savica R; Graff-Radford J; Jones DT; Botha H; St Louis EK; Knopman DS; Ramanan VK; Ross O; Graff-Radford N; Day GS; Dickson DW; Ferman TJ; Petersen RC; Lowe VJ; Boeve BF; Kantarci K Neurology; 2023 Jul; 101(2):e178-e188. PubMed ID: 37202168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]